Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India
· Delayed Price · Currency is INR 69.20
-1.28 (-1.82%)
At close: Mar 9, 2026
BOM:524412 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 14.73 | 15.94 | 7.06 | 1.92 | 6.5 | Upgrade
|
| Short-Term Investments | - | 17.56 | 12.95 | 4.18 | - | - | Upgrade
|
| Cash & Short-Term Investments | 81.9 | 32.29 | 28.9 | 11.24 | 1.92 | 6.5 | Upgrade
|
| Cash Growth | 449.78% | 11.75% | 157.15% | 485.62% | -70.46% | 29.24% | Upgrade
|
| Accounts Receivable | - | 1,335 | 1,845 | 1,898 | 1,363 | 1,620 | Upgrade
|
| Other Receivables | - | 4.11 | 0.33 | 0.33 | 1.3 | - | Upgrade
|
| Receivables | - | 1,634 | 2,000 | 1,988 | 1,364 | 1,620 | Upgrade
|
| Inventory | - | 716.86 | 719.94 | 651.79 | 561.16 | 469.27 | Upgrade
|
| Restricted Cash | - | - | - | - | - | 27.72 | Upgrade
|
| Other Current Assets | - | 272.58 | 76.78 | 54.77 | 260.75 | 59.96 | Upgrade
|
| Total Current Assets | - | 2,656 | 2,826 | 2,706 | 2,188 | 2,184 | Upgrade
|
| Property, Plant & Equipment | - | 162.21 | 129.61 | 139.37 | 144.67 | 142.58 | Upgrade
|
| Long-Term Investments | - | 21.23 | 13.88 | 4.08 | 27.97 | 4 | Upgrade
|
| Other Long-Term Assets | - | 56.64 | 56.53 | 55.96 | 51.1 | - | Upgrade
|
| Total Assets | - | 2,906 | 3,033 | 2,913 | 2,452 | 2,330 | Upgrade
|
| Accounts Payable | - | 1,025 | 1,289 | 1,273 | 1,097 | 1,103 | Upgrade
|
| Accrued Expenses | - | -35.26 | -1.74 | -11.44 | 3.67 | 6.2 | Upgrade
|
| Short-Term Debt | - | 415.62 | 281.28 | 333.58 | 108.23 | 180.17 | Upgrade
|
| Current Income Taxes Payable | - | 14.02 | 38.48 | 50.56 | 48.25 | 16.64 | Upgrade
|
| Other Current Liabilities | - | 72.27 | 58.03 | 35.4 | 10.6 | 1.63 | Upgrade
|
| Total Current Liabilities | - | 1,492 | 1,665 | 1,681 | 1,267 | 1,308 | Upgrade
|
| Long-Term Debt | - | 19.87 | 32.24 | 43.61 | 33.4 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 9.19 | 7.49 | 14.15 | 14.55 | 15.63 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | -0 | -0 | 18.08 | Upgrade
|
| Total Liabilities | - | 1,521 | 1,705 | 1,739 | 1,315 | 1,342 | Upgrade
|
| Common Stock | - | 284.54 | 280.54 | 253.85 | 253.85 | 233.85 | Upgrade
|
| Additional Paid-In Capital | - | 501.79 | 489.28 | 410.84 | 410.84 | 348.52 | Upgrade
|
| Retained Earnings | - | 571.32 | 531.26 | 484.25 | 446.53 | 381.09 | Upgrade
|
| Comprehensive Income & Other | - | 27.15 | 26.65 | 25.15 | 25.15 | 25.15 | Upgrade
|
| Shareholders' Equity | 1,489 | 1,385 | 1,328 | 1,174 | 1,136 | 988.6 | Upgrade
|
| Total Liabilities & Equity | - | 2,906 | 3,033 | 2,913 | 2,452 | 2,330 | Upgrade
|
| Total Debt | 569.6 | 435.49 | 313.52 | 377.18 | 141.63 | 180.17 | Upgrade
|
| Net Cash (Debt) | -487.7 | -403.2 | -284.63 | -365.94 | -139.71 | -173.67 | Upgrade
|
| Net Cash Per Share | -17.08 | -14.27 | -11.20 | -14.36 | -5.80 | -7.43 | Upgrade
|
| Filing Date Shares Outstanding | 28.45 | 28.45 | 28.05 | 25.38 | 25.38 | 23.38 | Upgrade
|
| Total Common Shares Outstanding | 28.45 | 28.45 | 28.05 | 25.38 | 25.38 | 23.38 | Upgrade
|
| Working Capital | - | 1,164 | 1,160 | 1,025 | 920.81 | 875.74 | Upgrade
|
| Book Value Per Share | 53.06 | 48.67 | 47.33 | 46.25 | 44.77 | 42.28 | Upgrade
|
| Tangible Book Value | 1,489 | 1,385 | 1,328 | 1,174 | 1,136 | 988.6 | Upgrade
|
| Tangible Book Value Per Share | 53.06 | 48.67 | 47.33 | 46.25 | 44.77 | 42.28 | Upgrade
|
| Land | - | 3.79 | 3.79 | 3.79 | 3.79 | 2.24 | Upgrade
|
| Buildings | - | 46.15 | 39.12 | 39.12 | 39.01 | 39.01 | Upgrade
|
| Machinery | - | 341.02 | 296.01 | 288.79 | 278.46 | 258.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.